- Endocrine cancer
-
Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea
-
Hwa Young Ahn, Ra-Yeong Song, Hye Shin Ahn, Hee Sung Kim
-
Cancer Res Treat. 2021;53(4):1204-1212. Published online February 10, 2021
-
DOI: https://doi.org/10.4143/crt.2020.1201
-
-
Abstract
PDFPubReaderePub
- Purpose
The aim of this study was to examine the rate of expression of estrogen receptor α (ERα) and β1 (ERβ1), progesterone receptor (PR), and rate of overexpression of epidermal growth factor receptor (EGFR) in a relatively large cohort of patients with papillary thyroid carcinoma (PTC). We also aimed to examine whether each receptor influenced clinicopathological characteristics and prognosis of PTC.
Materials and Methods We made a microarray of paraffin-embedded PTC surgical tissues from 436 patients. We compared the results of the immunohistochemical staining for each hormone receptor with clinicopathological characteristics.
Results The positive expression rate of hormonal receptors was 40.4% for ERα, 83.7% for ERβ1, and 71.3% for PR in patients with PTC. Overexpression of EGFR was shown in 19.3% of patients with PTC. The age was lower (44.6±12.1 years vs. 47.1±12.5 years, p=0.040) and tumor smaller (0.96±0.69 cm vs. 1.13±0.82 cm, p=0.020) in the ERα positive group, which also showed higher PR positivity (80.7% vs. 65.0%, p < 0.001) and overexpression of EGFR (27.3% vs. 13.8%, p < 0.001). However, neither the positivity of hormone receptors nor overexpression of EGFR affected the recurrence of PTC.
Conclusion In conclusion, most (94.6%) patients with PTC were found to exhibit positive expression for ERs or PR. We also found that neither the positive expression of hormone receptors nor overexpression of EGFR were associated with the recurrence of PTC.
-
Citations
Citations to this article as recorded by
- Struma Ovarii during Pregnancy
Gabriela Dumachița-Șargu, Răzvan Socolov, Teodora Ana Balan, Dumitru Gafițanu, Mona Akad, Raluca Anca Balan Diagnostics.2024; 14(11): 1172. CrossRef - Serum sex hormones correlate with pathological features of papillary thyroid cancer
Fa-Zhan Xu, Lu-Lu Zheng, Ke-Hao Chen, Ru Wang, Dan-Dan Yi, Chao-Yu Jiang, Zhi-Jian Liu, Xian-Biao SHI, Jian-Feng Sang Endocrine.2023; 84(1): 148. CrossRef - Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors
Florian Viehweger, Lisa-Marie Tinger, David Dum, Natalia Gorbokon, Anne Menz, Ria Uhlig, Franziska Büscheck, Andreas M. Luebke, Claudia Hube-Magg, Andrea Hinsch, Doris Höflmayer, Christoph Fraune, Patrick Lebok, Sören Weidemann, Maximilian Lennartz, Frank Analytical Cellular Pathology.2022; 2022: 1. CrossRef - Case report: Lymph node metastases of breast cancer and thyroid cancer encountered in axilla
Rihan Li, Qingfu Zhang, Dongdong Feng, Feng Jin, Siyuan Han, Xinmiao Yu Frontiers in Oncology.2022;[Epub] CrossRef
-
5,889
View
-
130
Download
-
5
Web of Science
-
4
Crossref
|